We already know that MACE rates for advanced kidney disease patients was drastically lower than the control group. 

So if RVX was to put something like "changes in eGFR" in the title, would that not be tantamount to saying wink wink, eGFR went up with the dosed group?  A de facto letting the cat out of the bag?  So maybe RVX decided not to say anything at all?